Invasive disease-free survival with anthracyclines in early breast cancer

Forest plots of (panel A) invasive disease-free survival hazard ratio (HR) according to stratification variables, and (panel B) with test for interaction by combined hormone receptor and nodal status. TaxAC, doxorubicin, and cyclophosphamide regimens with a taxane; TC, docetaxel, and cyclophosphamide.